9
Clinical Trials associated with Evogliptin Tartrate/Metformin Hydrochloride / Not yet recruitingPhase 1 An Open Label, Randomized, Single Dose, Cross-over ,Two-group Study to Evaluate the Pharmacokinetics and Safety of DA-1229_01 5/1000mg in Healthy Subjects at Fed State
This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229_01(5/1000 mg x1 tablets) at fed state.
/ Not yet recruitingPhase 1 An Open Label, Randomized, Single Dose, Cross-over ,Two-group Study to Evaluate the Pharmacokinetics and Safety of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State
This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229_01 (5/1000 mg x1 tablets) at fasting state.
/ Not yet recruitingPhase 1 An Open Label, Randomized, Single Dose, Cross-over ,Two-group Study to Evaluate the Pharmacokinetics and Safety of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State
This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229_01(2.5/500 mg) at fasting state.
100 Clinical Results associated with Evogliptin Tartrate/Metformin Hydrochloride
100 Translational Medicine associated with Evogliptin Tartrate/Metformin Hydrochloride
100 Patents (Medical) associated with Evogliptin Tartrate/Metformin Hydrochloride
100 Deals associated with Evogliptin Tartrate/Metformin Hydrochloride